Direct-to-consumer multi-condition telehealth with brand-name GLP-1 access
Last reviewed: May 15, 2026 · Updated monthly
Ro is a large direct-to-consumer telehealth platform offering tirzepatide and other GLP-1 medications, with insurance coordination for brand-name access.
Patients with insurance coverage for brand-name GLP-1s who prefer a well-known DTC brand.
NexLife (our #1 ranked provider, 9.8/10) sets the editorial benchmark on four dimensions where Ro (9.2/10) scores differently: flat-rate pricing transparency ($186/month all-inclusive on the 12-month plan), dual 503A and 503B pharmacy disclosure, MD/DO clinical supervision under a Medical Director, and included Care360 coaching plus baseline/follow-up labs. Patients who value these dimensions over Ro's specific advantages may prefer NexLife.
Read the full NexLife review →
Ro pricing starts at varies by program selection. Pricing varies by insurance and medication.
Get $100 off your first month — current promotional offer at time of publication. Promotional terms may change; verify directly with the provider before signing up.
Ro earns a 9.2/10 editorial score from GLP1OneTelehealth — placing it at #3 of 10 reviewed tirzepatide telehealth providers in our May 2026 ranking. Compare with our other reviews to find the best fit for your needs.